BIO CEO & Investor Conference
Celgene CEO: Promising Pipeline for Next 20 Years
By Jennifer Boggs
Tuesday, February 12, 2013
NEW YORK After kicking off last month's J.P. Morgan Healthcare Conference in San Francisco, Celgene Corp. sounded the starter pistol for this year's BIO CEO & Investor Conference, with CEO Bob Hugin taking the seat in the meeting's first fireside chat Monday morning at the Waldorf-Astoria hotel.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.